Historical record - last NADAC effective date: 7/1/2017
Product Information
LANOXIN 250 MCG TABLET is a brand product labeled by Advanz Pharma (US) Corp., priced at $12.1565 per EA under NDC 59212024955. Its NADAC has been published 127 times since Feb 10, 2016.
FDA first approved this application on Sep 30, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the digoxin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.25 mg/1
Manufacturer
Advanz Pharma (US) Corp.NDC
59212024955
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
7/1/2017
Active Ingredients
DIGOXINApproval Type
New Drug (NDA)
FDA Application
NDA020405FDA Approved
9/30/1997
TE Code
AB
On Market Since
9/30/2012
Pharmacological Classes
Price Statistics
The NADAC for LANOXIN 250 MCG TABLET has been published 127 times since Feb 10, 2016, and over the history we have for it it has risen 74.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.1565 per EA |
|---|---|
| All-time high | $12.1565 (Jul 11, 2018) |
| All-time low | $6.9518 (Feb 10, 2016) |
| Median price | $10.2155 |
| Average price | $10.0850 |
| Largest weekly change | +45.0% (Oct 26, 2016) |
| Weeks tracked | 127 |
| Tracking since | Feb 10, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+74.9%
Last surveyed Jul 11, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the digoxin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LANOXIN 250 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LANOXIN 250 MCG TABLET, manufactured by Advanz Pharma (US) Corp., is $12.1565 per EA (NDC 59212024955), effective Jul 11, 2018.
How has the price of LANOXIN 250 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LANOXIN 250 MCG TABLET has risen 74.9%. It has been tracked across 127 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for LANOXIN 250 MCG TABLET?
Since Feb 10, 2016, the NADAC for LANOXIN 250 MCG TABLET has ranged from a low of $6.9518 (Feb 10, 2016) to a high of $12.1565 (Jul 11, 2018), with a median of $10.2155 per EA.
Are there cheaper alternatives to LANOXIN 250 MCG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of LANOXIN 250 MCG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LANOXIN 250 MCG TABLET?
LANOXIN 250 MCG TABLET (NDC 59212024955) is labeled by Advanz Pharma (US) Corp., and CMS classifies it as a brand product.